Sanofi Consumer Healthcare India Limited (NSE:SANOFICONR)

Market Cap	96.32B -19.3%
Revenue (ttm)	9.50B +31.2%
Net Income	2.66B +33.0%
EPS	115.49 +33.0%
Shares Out	23.03M
PE Ratio	36.21
Forward PE	34.62
Dividend	75.00 (1.79%)
Ex-Dividend Date	Jun 19, 2026

Volume	4,652
Open	4,140.00
Previous Close	4,137.80
Day's Range	4,070.10 - 4,220.30
52-Week Range	3,975.00 - 5,357.00
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 29, 2026

About NSE:SANOFICONR

Sanofi Consumer Healthcare India Limited operates as a fast-moving consumer healthcare company in India. The company offers products in the allergy, physical wellness, and pain care segments under Allegra, Combiflam, Avil, DePURA, Festal, and other brand names through distributors, wholesalers, government institutions and hospitals, pharmacy chains, and e-commerce platforms. The company was incorporated in 2023 and is based in Mumbai, India. Sanofi Consumer Healthcare India Limited operates as a subsidiary of Opella Healthcare Participations B....

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 2023
• Employees: 597
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: SANOFICONR

Financial Performance

In 2025, NSE:SANOFICONR's revenue was 8.78 billion, an increase of 21.24% compared to the previous year's 7.25 billion. Earnings were 2.40 billion, an increase of 32.65%.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Sep 2, 2026

Data Sources Report a data error